A prospective open study evaluating the use of botulinum toxin in patients with overactive bladder as an alternative to other conservative treatments
Phase of Trial: Phase IV
Latest Information Update: 08 Aug 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 25 Apr 2019 Primary endpoint (Change from baseline in Overactive Bladder Symptom Score (OABSS)) has been met, according to results published in an Urology Journal.
- 25 Apr 2019 Results presented in an Urology Journal.
- 12 Jul 2018 New trial record